10th Annual Babson Healthcare & Life Sciences Forum

Driving Innovation and Entrepreneurship

Babson Healthcare and Life Sciences Club is hosting a half-day Forum bringing together industry, academic and entrepreneurial leaders to discuss challenges, opportunities and innovative ideas for the healthcare and life sciences sector. We will examine topics that have the greatest opportunity and impact, including innovation in therapeutic design and delivery, powerful uses for data analytics in healthcare, opportunities and challenges facing start-ups and the impact of payer/provider on patient care. The conference provides a platform for healthy debates surrounding these topics and provides an excellent opportunity for new business ideas and professional development.

Event Details:
Date: Friday, February 15, 2013
Time: Registration/Lunch starts at 11:00am
Location: Babson College 231 Forest Street Wellesley, MA 02481

Agenda

Keynote Speakers

Alexandra Drane

Alexandra Drane sets the vision and strategy for Eliza, and is responsible for maintaining Eliza’s leadership position in the healthcare industry. She has devoted her career to inspiring people to lead healthier, happier and more productive lives through the use of innovative technology, and her entrepreneurial spirit and passion for technology and design have led to the launch of four successful healthcare ventures over the past 15 years. Alexandra has proven herself a visionary and an innovator, whose ideas on using technology to engage people in their health – and her belief in adding a touch of joy to the often staid world of healthcare communications – have been adopted by the nation’s top healthcare organizations.

Alexandra is currently Founder, Chief Visionary Officer, and Chairman of the Board of Eliza Corporation, the pioneer and leader in Health Engagement Management and one of Entrepreneur magazine’s “100 Brilliant Companies”. The Company’s intelligent, tailored interactions—including automated calls powered by a patented speech recognition engine, rich web and multi-modal delivery platform and proprietary sophisticated data analytics—make health and healthcare information more accessible, more actionable and more engaging.

Eliza draws on its database of more than 800 million interactions with individuals about their health to better understand what makes people “tick” and create programs with measurable and sustained impact. Examples include increasing the number of patients who get their recommended diabetes screenings by 76%; more than doubling prescription refills over a six-month period; quadrupling participation in an online smoking cessation program; and boosting younger members’ perceptions of their health plans’ brands beyond what far more expensive traditional advertising campaigns deliver. But perhaps most important are the countless saved lives as the result of timely, personalized health outreach.

Alexandra is also a co-founder of Engage with Grace, a not-for-profit movement launched in October 2008 aimed at helping people understand, communicate and have honored their end-of-life wishes. She received the Boston Business Journal’s “Champions of Healthcare” award for her efforts in this area, and Engage with Grace has been added to the healthcare lexicon as a top-ten phrase.

Based on her experience engaging people in conversation about health topics, in 2010 she co-founded a non-profit, web-based movement called SeduceHealth that aims to reframe how the healthcare industry communicates with the people it serves by adding greater passion, joy, and inspiration.

Prior to founding Eliza, Alexandra was a founder of three other healthcare ventures – all focused on developing products that enable individual behavior change through the use of technology. The output of these ventures included the web-enabled injury-tracking software system adopted by the U.S. Olympic Committee, software that automates dialysis clinics across the U.S., and a medical device proven in clinical trials to improve asthma treatment compliance by over 35%.

Alexandra sits on the Board of Eliza, the Board of Advisors of TEDMED, the Harvard Executive Sleep Council, and is Vice Chair of the Board of Trustees for Beth Israel Deaconess Medical Center (a Harvard Teaching Hospital) in Boston, MA. She also sits on the Board of Directors and the Operations Committee of the Coalition to Transform Advanced Care (C-TAC) and co-chairs C-TAC’s Public Engagement Workgroup. Alexandra is a member of the Health Executive Leadership Network, Women Business Leaders of the U.S. Health Care Industry Foundation, and is a trustee of several charitable trusts.

Alexandra has been named to the Boston Business Journal’s “40 Under 40” list and also appears on the Healthspottr Future Health 100 list, which includes some of the most creative and influential people working in healthcare today.

Rodrigo Martinez

Rodrigo Martinez is passionate about the crossroads of design + biology at all scales. As Life Sciences Chief Strategist at IDEO and member of the Health & Wellness practice, he tackles some of the most interesting challenges in health care, life sciences, and the emerging wellness space. With his colleagues in Boston, Rodrigo is also experimenting different approaches to design with living organisms.

Rodrigo learned to love science-by-doing at the Exploratorium in San Francisco - first as a seven-year-old, and later working there as a teenager. Before joining IDEO, he was a principal with The Boston Consulting Group in the health care practice. With Juan Enriquez, Rodrigo co-founded Harvard Business School’s Life Sciences Project and coined the term ‘bioeconomy’ in a series of papers and articles starting in 1997. In 2003, he co-published the first global genetic data map selected by Rem Koolhaas to be part of a WIRED’s ‘Ultimate Atlas for the XXI Century.’

Rodrigo is a regular guest lecturer at Harvard and MIT on topics including innovation, design and entrepreneurship, health and wellness. Educated at Mexico City’s ITAM and Harvard, Rodrigo mostly learns creativity, innovation, and prototyping from his 5-year-old daughter. Rodrigo loves spicy food and is a runner, you can follow him on Twitter at @RodrigoATCG .

Panel 1A: From Concept to Commercialization: The Pathway to Launch

In this current environment, entrepreneurs are facing decreasing availability of venture financing, growing competition and a complex regulatory backdrop from which to evaluate new business opportunities. In this panel, we will focus on some of the obstacles that face life sciences start-ups and discuss tools and insights in overcoming them to create successful ventures in this challenging economy.

Moderator
Candy Brush, Faculty, Blank Center for Entrepreneurship

Panelists
Perry Mykleby, Founding Partner, MakerStaker, LLC
David Mills, President & CEO, Dallen Medical
Suresh Pai, Co-Founder, Axiom Technology Partners, LLC
Tom Keegan, VP of Business Development, NLT Spine

Panel 1B: Healthcare Data Analytics: Improving Patient Outcomes

The reimbursement model for Hospitals and Providers is changing from fee for service to fee per outcome. This panel will focus on how harnessing IT systems and Data Analytics allow Insurance Companies and Providers to analyze and share data to increase positive patient outcomes and therefore lower healthcare costs and promote a healthier patient population.

Moderator
Yunwei Gai, Faculty, Babson College Economics Department

Panelists
Paul Quigley, Founder and CEO, Cornerstone Healthcare Consulting
Paul Aseltine, Manager of Informatics, New England Quality Care Alliance
Karthik Mukund, Director of Project Management, eClinicalWorks

Panel 2A: Entrepreneurship/Venture Capital in Healthcare: Connections

The changing landscape of healthcare has impacted the way that doctors and patients administer and receive care. In this ever-changing context how do new business ideas and ventures come to light? The Entrepreneurship and Venture Capital panel will examine how entrepreneurs and venture capitalists drive innovation in healthcare and ultimately bring value to patients and providers.

Moderator
Philip Licari, Babson Faculty

Panelists
Yumin Choi, Senior Associate, HLM Venture Partners
Nandan Padukone, Vice President, Office of Commercialization & Ventures: Joslin Diabetes Center
Marc Duey, President, Prometrics

Panel 2B: The Changing BioPharma Model

The BioPharma industry has developed from virtually zero to a $140 billion market in the past 20 years. Now the focus for managers has shifted from how to absorb the fast growth to how to build a sustainable market. Pressure on revenues due to expiring patents and the increase of biosimilars, a change in production technology and new competitors from developing nations will be issues that future managers need to tackle.

Moderator
John Gordon, Partner at Putnam Associates

Panelists
Omar Francone, Senior Director Discovery Research, Shire
Doyle Johnson, Operations Leader, Hargrove Life Sciences, LLC
Eric Kimble, Vice President Program and Portfolio Development, Cubist

Afternoon Panel A: Globalization and Innovation in Emerging Markets: Is this the Next New Opportunity?

Globalization, for years now, has been thought of as a means to bring products and services from the developed world to the developing, but this model has become obsolete. The aim of the panel is to discuss the innovation that emerging markets are demanding from healthcare companies. It's time to rethink every aspect of operations, product portfolios, and business models in high growth markets. This panel will discuss how companies are already doing that as part of their growth plan in emerging markets and where there is room for improvement.

Moderator
Marty Anderson, Faculty, Babson College

Panelists
Priya Menon, Associate Platform Director, DePuy Mitek
Jeff Takle, Director of Innovations Lab, Abt Associates
Rishi Saurabh, Global Product Marketing Manager, Integrated Care-Financial and Risk Management, GE Healthcare
Anthony Pannozzo, Managing Principal, Research & Innovation, Continuum
Elizabeth Bailey, Director, Consortium for Affordable Medical Technology, Mass General Hospital

Afternoon Panel B: Design & Innovation in Healthcare: From Devices to Diagnostics to Drugs

In recent years the healthcare industry has experienced intensifying pressure to reduce costs and increase the level of care.   This pressure has led to new legislation that is quickly changing the healthcare landscape. Changes include a shift from acute to at home care, reactionary to preventative care and payment based on positive results, not the number of procedures performed.  These changes are putting additional pressure on device, diagnostic and drug companies to find innovative solutions at a lower cost.  This panel will focus on the current issues facing these companies and the steps they are taking to innovate and adapt to the new environment.

Moderator
Sebastian Fixson, Faculty, Babson College Technology and Operations Department

Panelists
Mike Dunkley, Vice President of Product Development in continuum's Advanced Systems Division
Daniel Graf, Founder of Ovatemp
Rob Havasy, Technical Architect and Senior Consultant at the Center for Connected Health as well as on the Board of Directors for Continua.

Poster Session

Do you have exciting health/life sciences research? Do you want to meet people in the business side of biotechnology?  Present your work at the Healthcare and Life Sciences Poster Session!  Presenters receive FREE admission to the entire conference (max two presenters per poster) and present during the Networking Reception.  Contact us HERE by Monday, February 8, 2013.

Deadline to sign up is February 8, 2013.